Toca 6: A phase 1b study of Toca 511 and Toca FC in patients with advanced solid tumors or lymphoma

Journal article

Peer reviewed

Jaime R Merchan, Jordi Rodon Ahnert, Gerald Falchook, Derek Ostertag, Dalissa Tejera, Harry E Gruber, Douglas J Jolly and Jolene Shorr

Journal of clinical oncology, Vol.36(15_suppl), pp.TPS2613-TPS2613

2018-05-20

Metrics

64 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Toca 6: A phase 1b study of Toca 511 and Toca FC in patients with advanced solid tumors or lymphoma
Creators: Jaime R Merchan - University of Miami, Miami, FL
Jordi Rodon Ahnert - Vall d'Hebron University Hospital, Barcelona, Spain
Gerald Falchook - Sarah Cannon Research Institute at HealthONE, Denver, CO
Derek Ostertag - Tocagen, Inc., San Diego, CA
Dalissa Tejera - Sylvester Comprehensive Cancer Center, Miami, FL, US
Harry E Gruber - Tocagen, Inc., San Diego, CA
Douglas J Jolly - Tocagen, Inc., San Diego, CA
Jolene Shorr - Tocagen, Inc., San Diego, CA
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.TPS2613-TPS2613
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600156702976